share_log

Mirae Asset Global Investments Co. Ltd. Increases Stock Position in AMETEK, Inc. (NYSE:AME)

Defense World ·  Sep 26, 2022 04:21

Mirae Asset Global Investments Co. Ltd. boosted its stake in AMETEK, Inc. (NYSE:AME – Get Rating) by 19.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,852 shares of the technology company's stock after purchasing an additional 3,443 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in AMETEK were worth $2,777,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Gryphon Financial Partners LLC purchased a new stake in AMETEK in the first quarter valued at approximately $25,000. Quent Capital LLC raised its stake in shares of AMETEK by 177.8% during the first quarter. Quent Capital LLC now owns 200 shares of the technology company's stock worth $27,000 after acquiring an additional 128 shares in the last quarter. Covestor Ltd raised its stake in shares of AMETEK by 84.3% during the first quarter. Covestor Ltd now owns 212 shares of the technology company's stock worth $28,000 after acquiring an additional 97 shares in the last quarter. Prospera Financial Services Inc purchased a new position in shares of AMETEK during the first quarter worth approximately $29,000. Finally, Intelligent Financial Strategies purchased a new position in shares of AMETEK during the fourth quarter worth approximately $35,000. 85.46% of the stock is owned by hedge funds and other institutional investors.

Get AMETEK alerts:

AMETEK Stock Performance

NYSE:AME opened at $114.43 on Monday. The stock has a market cap of $26.27 billion, a P/E ratio of 24.35, a price-to-earnings-growth ratio of 2.22 and a beta of 1.26. The firm's fifty day simple moving average is $122.17 and its 200 day simple moving average is $122.18. AMETEK, Inc. has a twelve month low of $106.17 and a twelve month high of $148.07. The company has a quick ratio of 0.88, a current ratio of 1.48 and a debt-to-equity ratio of 0.31.

AMETEK (NYSE:AME – Get Rating) last released its quarterly earnings results on Tuesday, August 2nd. The technology company reported $1.38 earnings per share for the quarter, beating the consensus estimate of $1.29 by $0.09. The business had revenue of $1.51 billion for the quarter, compared to analysts' expectations of $1.46 billion. AMETEK had a net margin of 18.49% and a return on equity of 18.20%. The firm's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.15 earnings per share. As a group, research analysts predict that AMETEK, Inc. will post 5.52 EPS for the current year.

AMETEK Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 30th. Stockholders of record on Wednesday, September 14th will be issued a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date is Tuesday, September 13th. AMETEK's dividend payout ratio (DPR) is presently 18.72%.

Wall Street Analyst Weigh In

Several research firms have commented on AME. Morgan Stanley lifted their price target on shares of AMETEK from $135.00 to $145.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 3rd. Mizuho lifted their price target on shares of AMETEK from $135.00 to $140.00 and gave the stock a "buy" rating in a research note on Wednesday, August 3rd. StockNews.com upgraded shares of AMETEK from a "hold" rating to a "buy" rating in a report on Friday, September 16th. DA Davidson raised their target price on shares of AMETEK to $160.00 in a report on Tuesday, August 9th. Finally, Loop Capital cut their target price on shares of AMETEK from $170.00 to $155.00 and set a "buy" rating on the stock in a report on Tuesday, July 19th. Two research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, AMETEK presently has an average rating of "Moderate Buy" and a consensus price target of $148.56.

Insider Activity

In other news, Director Steven W. Kohlhagen sold 3,000 shares of the business's stock in a transaction on Wednesday, August 10th. The shares were sold at an average price of $126.81, for a total transaction of $380,430.00. Following the sale, the director now owns 45,964 shares in the company, valued at approximately $5,828,694.84. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, Director Steven W. Kohlhagen sold 3,000 shares of AMETEK stock in a transaction dated Wednesday, August 10th. The stock was sold at an average price of $126.81, for a total value of $380,430.00. Following the completion of the transaction, the director now owns 45,964 shares of the company's stock, valued at approximately $5,828,694.84. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Steven W. Kohlhagen sold 3,100 shares of AMETEK stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $123.75, for a total value of $383,625.00. Following the completion of the transaction, the director now directly owns 42,864 shares of the company's stock, valued at approximately $5,304,420. The disclosure for this sale can be found here. Company insiders own 0.72% of the company's stock.

AMETEK Company Profile

(Get Rating)

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.

Read More

  • Get a free copy of the StockNews.com research report on AMETEK (AME)
  • Can Caterpillar Claw Higher in a Falling Market?
  • Is Dave & Buster's Immune to High Inflation and Lower Spending?
  • Should These 3 Top-Performing Mid-Caps Be On Your Watchlist?
  • Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
  • MarketBeat: Week in Review 9/19 – 9/23

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Get Rating).

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment